Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Enhancing Success of Ultrasound-Guided Neuraxial Anesthesia in Cases with Difficult Anatomy
Published on: January 31, 2025
Estimation of the Effective Dose of Phenylephrine Infusion for Preventing Spinal Anesthesia-Induced Hypotension in
Soumya R Sahoo1, Devdutta Raiguru2, Anusha Kakarla3
1Department of Anesthesiology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Introduction:
Spinal anesthesia for cesarean delivery may be associated with hypotension and fetal acidosis. Phenylephrine, an α1 adrenergic receptor agonist, is effective in treating hypotension with the benefit of less placental transfer.
Objective:
The objective of this study was to determine the optimum dose of prophylactic phenylephrine infusion for preventing spinal anesthesia-induced hypotension in women undergoing elective cesarean delivery and to assess its effect on fetal outcomes, as measured by APGAR scores at 1, 5, and 10 minutes.
Methodology:
Two hundred and forty patients were included in this double-blinded study. Women undergoing elective cesarean section were preloaded with crystalloids and then randomly allocated to receive prophylactic Phenylephrine infusion at either 25, 50, 75, or 100 µg/minute immediately after spinal anesthesia (Groups A, B, C, and D, respectively). Maternal hemodynamic parameters, total dose of phenylephrine used, APGAR score, and incidence of maternal complications like reactive hypertension, bradycardia, nausea, and vomiting, as well as fetal complications like fetal acidosis, were noted. The study was registered with the Clinical Trials Registry of India (CTRI/2019/07/020231, dated July 17, 2019) Results: Demographic parameters were comparable across all four groups (P > 0.05). The incidence of maternal hypotension was lowest in Group B (50 µg/minute) at 15.0%, compared to 41.7% in Group A, 30.0% in Group C, and 23.3% in Group D (P = 0.001). Maternal adverse events such as nausea/vomiting occurred in 5% of Group B, 28.3% of Group A, 31.7% of Group C, and 20% of Group D (P = 0.016). Mean phenylephrine requirements were 692 ± 67 µg (Group A), 1,269 ± 120 µg (Group B), 592 ± 115 µg (Group C), and 439 ± 83 µg (Group D) (P < 0.001). Mean APGAR scores at 1 minute were above 8.4 for all groups; all neonates had mean APGAR scores above 9.8 by 5 minutes (P > 0.05). Maternal complications such as bradycardia ranged from 25% to 63% across groups. The frequency of bradycardia was significantly higher in Groups C (63.3%) and D (60%) than in Groups A (26.7%) and B (25%) (P < 0.001). The 95% confidence intervals for major outcomes indicated statistical significance for these comparisons.
Conclusions:
We concluded that starting prophylactic Phenylephrine infusion at 50 µg/minute immediately after spinal anesthesia was an effective and simple method of reducing the incidence, frequency, and magnitude of hypotension in elective cesarean section with no adverse effect on neonatal outcome.
Related Concept Videos
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Clinical Application as Spinal Anesthesia

